Literature DB >> 16937462

Cytomegalovirus and inflammatory bowel disease: is there a link?

Valeria Criscuoli1, Maria-Rosa Rizzuto, Mario Cottone.   

Abstract

The objective of this report is to give an overall view of the epidemiological, clinical, diagnostic and therapeutic features of Cytomegalovirus (CMV) infection in inflammatory bowel disease (IBD). A review of published reports on this topic was carried out, with particular attention paid to the selection of patients included in studies and the diagnostic methods employed. CMV is frequently associated with IBD. In some cases, CMV infection is associated with a poor outcome but it is not clear which patients are more likely to be affected and in which stage of the disease. The use of anti-viral therapy in IBD is controversial and an empirical study with controls is needed. The natural history of CMV infection related to the development and treatment of IBD has not been clarified but it is important to take it in consideration because of the possibility of viral persistence in the immunocompromised host and viral interaction with the immune system.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16937462      PMCID: PMC4087614          DOI: 10.3748/wjg.v12.i30.4813

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  40 in total

1.  Cytomegalovirus: the taming of the beast?

Authors:  J Goodrich; N Khardori
Journal:  Lancet       Date:  1997-12-13       Impact factor: 79.321

2.  Outcome of cytomegalovirus infections in patients with inflammatory bowel disease.

Authors:  K A Papadakis; J K Tung; S W Binder; L Y Kam; M T Abreu; S R Targan; E A Vasiliauskas
Journal:  Am J Gastroenterol       Date:  2001-07       Impact factor: 10.864

3.  Polymerase chain reaction to evaluate antiviral therapy for cytomegalovirus disease.

Authors:  H Einsele; G Ehninger; M Steidle; A Vallbracht; M Müller; H Schmidt; J G Saal; H D Waller; C A Müller
Journal:  Lancet       Date:  1991-11-09       Impact factor: 79.321

Review 4.  Meta-analysis of outcome of cytomegalovirus colitis in immunocompetent hosts.

Authors:  Polymnia Galiatsatos; Ian Shrier; Esther Lamoureux; Andrew Szilagyi
Journal:  Dig Dis Sci       Date:  2005-04       Impact factor: 3.199

5.  Cytomegalovirus colitis in individuals without apparent cause of immunodeficiency.

Authors:  F H Ng; T N Chau; T C Cheung; C Kng; S Y Wong; W F Ng; K C Lee; E Chan; S T Lai; W C Yuen; C M Chang
Journal:  Dig Dis Sci       Date:  1999-05       Impact factor: 3.199

6.  Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis.

Authors:  M Cottone; G Pietrosi; G Martorana; A Casà; G Pecoraro; L Oliva; A Orlando; M Rosselli; A Rizzo; L Pagliaro
Journal:  Am J Gastroenterol       Date:  2001-03       Impact factor: 10.864

7.  Cytomegalovirus as an exacerbating factor in ulcerative colitis.

Authors:  E V Loftus; G L Alexander; H A Carpenter
Journal:  J Clin Gastroenterol       Date:  1994-12       Impact factor: 3.062

8.  Cytomegalovirus infection in steroid-refractory ulcerative colitis: a case-control study.

Authors:  Neeraja Kambham; Rohini Vij; Christine A Cartwright; Teri Longacre
Journal:  Am J Surg Pathol       Date:  2004-03       Impact factor: 6.394

9.  Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer.

Authors:  Lualhati Harkins; Andrea L Volk; Minu Samanta; Ivan Mikolaenko; William J Britt; Kirby I Bland; Charles S Cobbs
Journal:  Lancet       Date:  2002-11-16       Impact factor: 79.321

10.  Comparison of immunoperoxidase and DNA in situ hybridization techniques in the diagnosis of cytomegalovirus colitis.

Authors:  S S Robey; W R Gage; F P Kuhajda
Journal:  Am J Clin Pathol       Date:  1988-05       Impact factor: 2.493

View more
  16 in total

Review 1.  Probiotics and prebiotics in inflammatory bowel disease: microflora 'on the scope'.

Authors:  Dimitrios Damaskos; George Kolios
Journal:  Br J Clin Pharmacol       Date:  2008-02-12       Impact factor: 4.335

2.  Cytomegalovirus infection of the ileoanal pouch: clinical characteristics and outcomes.

Authors:  Jeffrey D McCurdy; Edward V Loftus; William J Tremaine; Thomas C Smyrk; David H Bruining; Darrell S Pardi; Laura E Raffals; John B Kisiel; Nayantara Coelho-Prabhu; Sunanda V Kane; William A Faubion; Konstantinos A Papadakis
Journal:  Inflamm Bowel Dis       Date:  2013-10       Impact factor: 5.325

3.  Cytomegalovirus Reactivation in Ulcerative Colitis Patients.

Authors:  Minh Nguyen; Kara Bradford; Xiaolan Zhang; David Q Shih
Journal:  Ulcers       Date:  2011-01-01

Review 4.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

Authors:  Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne
Journal:  Gut       Date:  2019-09-27       Impact factor: 23.059

5.  The impact of primary and persistent cytomegalovirus infection on the progression of acute colitis in a murine model.

Authors:  Jerry L Brunson; Felix Becker; Karen Y Stokes
Journal:  Pathophysiology       Date:  2014-11-18

6.  Clinical significance of cytomegalovirus infection in patients with inflammatory bowel disease.

Authors:  Elena Garrido; Elisa Carrera; Rebeca Manzano; Antonio Lopez-Sanroman
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

Review 7.  Environmental risk factors for inflammatory bowel diseases: Evidence based literature review.

Authors:  Ayokunle T Abegunde; Bashir H Muhammad; Owais Bhatti; Tauseef Ali
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

8.  Latent cytomegalovirus infection exacerbates experimental colitis.

Authors:  Chukwuma Onyeagocha; Mohammad S Hossain; Amrita Kumar; Rheinallt M Jones; John Roback; Andrew T Gewirtz
Journal:  Am J Pathol       Date:  2009-10-08       Impact factor: 4.307

9.  Environmental pathways to autoimmune diseases: the cases of primary biliary cirrhosis and multiple sclerosis.

Authors:  Carlo Selmi; Anna Maria Papini; Piera Pugliese; Maria Claudia Alcaro; M Eric Gershwin
Journal:  Arch Med Sci       Date:  2011-07-11       Impact factor: 3.318

10.  Metagenomic analysis of microbiome in colon tissue from subjects with inflammatory bowel diseases reveals interplay of viruses and bacteria.

Authors:  Weiwei Wang; Juan Jovel; Brendan Halloran; Eytan Wine; Jordan Patterson; Glenn Ford; Sandra OʼKeefe; Bo Meng; Deyong Song; Yong Zhang; Zhijian Tian; Shawn T Wasilenko; Mandana Rahbari; Salman Reza; Troy Mitchell; Tracy Jordan; Eric Carpenter; Karen Madsen; Richard Fedorak; Levinus A Dielemann; Gane Ka-Shu Wong; Andrew L Mason
Journal:  Inflamm Bowel Dis       Date:  2015-06       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.